CVE-2018-18975

Name: CVE-2018-18975
Creator: NVD / NIST
Published: 2019-05-06T20:29:00.307+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

UnknownEPSS 0.96%

Last modified Jun 17, 2026

CVE-2018-18975 is a vulnerability of currently unknown severity. An issue was discovered in the Ascensia Contour NEXT ONE app for iOS before 2019-01-15. An attacker may proxy communications between the app and Ascensia backend servers because of a weak certificate-pinning implementation, leading to disclosure of medical information.. EPSS estimates a 0.96% chance of exploitation in the next 30 days.

Description

An issue was discovered in the Ascensia Contour NEXT ONE app for iOS before 2019-01-15. An attacker may proxy communications between the app and Ascensia backend servers because of a weak certificate-pinning implementation, leading to disclosure of medical information.

Metrics

EPSS Probability

0.96%

57.1th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-200

Affected Software

Vendor	Product	Versions
Ascensia	Contour Diabetes	< 2.4.30

References

https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabeticExploit, Technical Description, Third Party Advisory
https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabeticExploit, Technical Description, Third Party Advisory

Timeline

Published: May 6, 2019
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2018-18975?

How severe is CVE-2018-18975?

Severity scoring for CVE-2018-18975 is pending analysis. The EPSS model estimates a 0.96% probability of exploitation in the next 30 days.

How do I fix CVE-2018-18975?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2018-18975?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST